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CHAPTER 5 
Peptide and Protein Hydrogels 
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California Institute of Technology, Division of Chemistry and Chemical 
Engineering, 1200 East California Boulevard, MC 210-41, Pasadena, 
CA 91125, USA 
*Email: tirrell(o caltech.edu 
5.1 Introduction 
Proteins are a fascinating class of macromolecules from both functional and 
structural perspectives. They catalyze the reactions that sustain life. bind 
ligands with h1gh affinity and specificity, and mediate interactions among 
biomolccules in complex cellular milieux. Proteins also assemble into higher-
order structures that arc responsible for the mechanical integrity of cells and 
tissues. Their diverse functional and structural properties have made proteins 
important building blocks in the development of new biomaterials. l-4 
Hydrogels are physically or chemically cross-linked polymer networks with 
high water content. 5·6 Their formation requires a balance between the forces 
driving the association of polymer chains and those mediating solvation of the 
network. Given that proteins have evolved to fold and function in aqueous 
environments and that many proteins self-assemble into larger structures, they 
would seem to be ideal candidates for use as hydrogel precursors. Indeed, 
proteins, and more broadly peptides of all sizes, are widely used for this 
purpose. 
The development of peptide and protein hydrogels has been a cross-
disciplinary effort combining the knowledge of protein structure and function 
from biology with the synthesis and characterization tools of macromolecular 
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chemistry and materials science. The primary motivation driving this field is the 
need for implantable scaffolds for soft-tissue enginecring,7·H benign methods for 
encapsulation of cells and biomolccules,9· 10 matrices for in vitro cell culture, 11 
and injectable delivery vehicles for therapcutics. 12.1 3 Moreover, peptide 
hydrogels show promise as templates for biomineralization 14 and inorganic 
nanostructures15 The ability of proteins to undergo biochemical and structural 
changes in response to pH and temperature changes, ligand binding, light, and 
mechanical force also suggests potential applications for peptide hydrogels as 
biosensors and stimulus-responsive materials. 16·17 Finally, peptide hydrogels 
provide simplified systems for studying and engineering the assembly of bio-
logical molecules as well as inspiration for the development of self-assembling 
synthetic structures. 
We identify four classes of peptide hydrogels: (!) hydrogels from self-
assembling oligopeptides, (2) hydrogels from recombinant proteins, (3) 
hydrogels that are hybrid materials combining peptides and proteins with 
synthetic polymers, and ( 4) hydrogels from naturally sourced proteins and 
proteoglycans such as collagen. Despite the importance of this last class of 
hydrogels in cell culture and tissue engineering applications, there are only 
limited opportunities for engineering and rational design of its macromolecular 
components, and detailed characterization can be challenging because of 
material heterogeneity. Therefore, after a brief background on peptide and 
protein structure, we will limit our discussion to examples from the first three 
classes of peptide hydrogels before concluding with future directions and 
challenges in this field. 
5.2 Peptide and Protein Structure 
Peptides are polymers formed by the condensation of amino acids. Short 
polymer chains with degrees of polymerization less than approximately 25 
amino acids are generally described as oligopeptides, while longer chains are 
known as polypeptides. The term protein will be reserved for polypeptides that 
have been synthesized by ribosomal translation. 
5.2.1 Peptide and Protein Synthesis 
The most basic level of protein structure is the linear sequence of amino acids, 
also known as the primary structure. The protein sequence is genetically 
encoded in DNA. or more specifically in the portion of the DNA that is 
transcribed into messenger RNA. Protein synthesis occurs on the ribosome. 
which translates the messenger RNA and catalyzes the formation of amide 
bonds between amino acids and the growing polypeptide chain. Through 
genetic engineering, it is possible to produce natural or artificial proteins in a 
wide variety of host organisms, typically Escherichia coli but occasionally yeast 
and higher eukaryotes. Recombinant protein production yields monodisperse 
polymers with precise sequence control that is not possible with synthetic 
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polymerization methods. Oligopeptides and short polypeptides arc synthesized 
in vitro using solid-phase peptide synthesis (SPPS), with an upper limit of 
approximately 50 amino acids. 18 In this method, the peptide chain remains 
tethered to a resin support as each residue is added by amide coupling of a 
protected amino acid and its subsequent deprotection. Longer sequences can be 
synthesized by combining oligopeptides using native chemical ligation. 19 
With a few important exceptions,20•21 nature incorporates only 20 different 
amino acids into proteins. These are known as the canonical or natural amino 
acids. While the number of ways in which these monomers can be combined is 
nearly infinite, the diversity of the canonical amino acid side chains is somewhat 
limited from the viewpoint of synthetic chemistry. From the perspective of 
investigators who wish to design new peptide and protein biomaterials. it is 
advantageous to augment the canonical amino acids with new monomers that 
carry more diverse functionality, including reactive groups for bioorthogonal 
chemistry,22·23 halogens,24 26 and photo-reactive moieties. 27 Furthermore. 
natural proteins contain exclusively L-amina acids. which can influence protein 
structure and biomaterial assembly. 2x Non-canonical amino acids can be 
incorporated into synthetic oligopeptides, assuming that their side chains do 
not interfere with the coupling and deprotection reactions or that suitable 
protecting groups arc available. Numerous strategies have also been described 
for the co-translational incorporation of non-canonical amino acids in a 
residuc-specific29 or site-specific manner.-' 0 
5.2.2 Higher-Order Structure and Hydrogel Assembly 
Protein secondary structure describes the local conformation of the peptide 
backbone. Different conformations arise from the rotational degrees of free-
dom of the N--C"l and Ca--C bonds. The most common secondary structures are 
the cr-hclix and ~-sheet, which arc characterized by extensive hydrogen bonding 
between amine and carbonyl groups. Other secondary structures include turns 
and loops, ~-hairpins, ~-spirals, and polyproline helices. As discussed in the 
next section, regular secondary structure is a common feature in peptide and 
protein hydrogels and provides a basis for classifying these materials. 
Tertiary structure is the spatial arrangement of all of the atoms in a protein. 
It may also be referred to as the folded state of a protein and is closely related to 
function. Many proteins also have a quaternary structure that describes the 
assembly of multiple polypeptide subunits. Typically these subunits associate 
noncovalently through hydrogen bonding, hydrophobic interactions, and salt 
bridges. Alternatively they may be bound covalently through disulfide bond 
formation or enzymatic cross-linking. The intermolecular interactions that arc 
responsible for protein quaternary structure closely resemble those that facil-
itate the self-assembly of peptide and protein hydrogels. 
In addition to classification based on the type of peptide precursor (i.e. 
oligopeptides, recombinant proteins, etc.) or secondary structures (i.e. ~-sheets. 
ex-helices. etc.), peptide hydrogels can also be described by the mechanism of 
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(a) Nanofibrous Hydrogels 
Parallel fibers I ;~ 
Perpendicular fibers 
Intramolecular loop 
(c) Chemically cross-linked Hydrogels I 
Figure 5.1 Three modes of a~semhly of peptide hydrogels. (a) Oligopeptidc pre-
cursors assemble into perpendicular or parallel nanofibers that entangle to 
form physically cross-linked gels. (b) Artificial proteins and peptide 
polymer hybrids contain physical cross-linking domains separated by 
water-soluble linkers. Noncovalent association of these domains gives rise 
to intermolecular cross-links and intramolecular loops, which further 
assemble into hydrogel netw·orks. (c) Hydrogels can also be formed by 
chemical cross-linking of reactive amino acid side chains such as the 
0-amine of lysine (K). 
network assembly. Figure 5.1 depicts three such mechanisms for forming 
peptide hydrogels. The first is the gelation of nanofibrous peptide assemblies 
and is observed predominantly with oligopeptide precursors. Gel formation 
in such systems involves supramolecular assembly of precursors into nano-
fibers, -tapes, -tubes. or -ribbons that entangle and form nonspecific physical 
cross-links. The second mode of assembly is observed in longer multidomain 
proteins and peptide-polymer hybrids. Network assembly results from the 
noncovalent association of physical cross-linking domains that are separated 
by water-soluble linker regions. The flnal assembly mode is chemical cross-
linking and involves covalent bond formation at reactive amino acid side chains 
such as lysine and cysteine. It should be noted, however. that these assembly 
mechanisms are not mutually exclusive. For example, nanofibrous hydrogcls 
from oligopcptidcs may be chemically cross-linked for increased stability and 
mechanical strength. 31 ·32 
Peptide and Protein Hydrogel.\· 97 
5.3 Hydrogels from Oligopeptides 
In a typical strategy' for preparing hydrogels from synthetic oligopeptidc'l. 
precursors self-assemble noncovalently into fibrous nanostructures that form 
gels through physical cross-linking and entanglements. The key to gel forma-
tion is the tuning of molecular and supramolecular interactions to produce a 
self-supporting network that docs not precipitate and is capable of immobi-
lizing water. The noncovalent interactions between self-assembling oligopep-
tides often mimic the secondary structures responsible for local protein 
conformation. However, because these interactions generally occur inter-
molecularly, they also represent a form of quaternary structure. 
Most examples of oligopeptidc hydrogcls utilize the ~-sheet motif to produce 
supramolecular fibers, with only a few recent examples describing the gelation 
of ex-helical pep tides and collagen mimetic polyproline helices (CMPs). This is 
slightly counterintuitive, given that certain natural analogs to :x-helical coiled 
coils and CMPs, keratin and collagen respectively, arc components of the 
hydrogel-like cytoskeleton and extracellular matrix. In contrast the closest 
natural analogs of ~-sheet oligopeptides are amyloids. protein aggregates with 
prominent roles in diseases such as Alzheimer's. Another example of hydrogel 
formation from oligopeptide building blocks is the supramolecular assembly 
and gelation of peptide amphiphiles (PAs). 13 Although these materials also 
exhibit some secondary structure, their self-assembly and nanostructurcs arc 
sufficiently different to warrant separate classification. 
5.3.1 ~-Sheet Peptide Hydrogels 
Zhang et a/. first observed the gelation of a self-complementary oligopeptide 
while investigating the EAK 16 sequence, Ac-(AEAEAKAK),-NH2• derived 
from the yeast Z-ONA binding protein zuotin. 34 The pattern of alternating 
alanine (A) and glutamic acid (E) or lysine (K) residues promotes the formation 
of ~-strands in which the hydrophobic and charged side-chains arc segregated 
to opposite sides of the peptide backbone. Hydrogen bonding between peptidcs 
leads to the formation of intermolecular ~~-sheets containing a hydrophobic Ala 
face and a charged Glu/Lys face. Upon addition of salt, the ~-sheets further 
assemble into filaments with diameters of I 0-20 nm as a result of hydrophobic 
bonding between Ala faces and ionic interactions between Glu,iLys faces. The 
filaments entangle to produce physical hydrogels. 
The self-assembly and gelation of EAK16 prompted the development of the 
rationally designed oligopeptide RAD16 or Ac-(RARADADA),-NH,. The 
replacement of Glu with aspartic acid (D) and Ly's with arginine (R) preserves 
both the alternating pattern of hydrophobic and charged amino acids and the 
self-complementarity of the acidic and basic rcsiducs.:1 5 As a result. RAD16 
also forms intermolecular ~-sheets that assemble into filaments and hydrogels. 
The EAK 16 and RAD16 pep tides support the attachment of a variety of cell 
types in J'itro and form the basis for the commercially available PuraMatrixiM 
hydrogel system for cell culture and encapsulation. :1o 
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Several addi tional peptide hydrogels are also based on sequences that form 
13-sheets. For example, Aggeli et a/. have investigated the secondary structure 
and self-assembly of two peptides derived from lysozyme and the trans-
membrane protein lsK as a functio n of the solvent dielectric constant and 
hydrogen bonding ability37 The resulting phase diagram led to the de novo 
design of DN I (Ac-QQRFQWQFEQQ-N H2), a n 11-residue peptide that forms 
anti parallel, intermolecular 13-sheets referred to as 13-tapes (Q =glutamine, 
F = phenylalanine, W = tryptophan). Hydrophobic and 1!- 1! in teractions 
between aromatic side chains may cause two 13-tapes to associate along their 
hydrophobic faces to form a 13-ribbon. TEM reveals helical and twisting 
behavior in 13-tapes and ribbons as well as higher-o rder self-assembly into fibrils 
and fibers 38·39 
An important consideration in many hydrogel applications is the abi lity to 
control the self-assembly process.40 For example, the EAK16 and RADI 6 
family of peptides requires physiological salt concentrations to form hydrogels. 
In water, electrostatic repulsions between like charges on opposing peptides 
result in a significant energy barrier for self-assembly. Ions lower this barrier 
and promote peptide gelation by forming an electric double layer that 
screens the repulsive charges and permits 13-sheet assembly4 1.42 Using the 
self-complementary oligopeptide FEK16 or (FEFEFKFK)z, Messersmith and 
co-workers have demonstrated controlled assembly of hydrogels by photo-
chemical and therma l release of CaCI2 from light- and temperature-sensitive 
liposomes43 Yu and co-workers have described an a lternative approach for 
controlling self-assembly that involves two complementary peptide sequences, 
Ac-WKVKVK VK VK-NH2 and Ac-EWEVEVEVEV-NH2 (V =valine). Under 
appropriate conditions, the individual peptides remain in solution because of 
ionic self-repulsion but assemble into nanofibers and hydrogels upon mixing due 
to the complementa ry acidic and basic residues.44 
The Pochan and Schneider groups have developed an elegant approach to 
controlling peptide gelation in which the intramolecular folding of a random 
coil into a 13-hairpin is a prerequisite for self-assembly and hydrogel formation 
(Figure 5.2). Their MAX peptides are derivatives of the rationally designed 
sequence VKVKVKVKV0 PPTKVKVKVKYK-NH2. 45 Whereas the a lternat-
ing pattern o f hydrophobic valine res idues and charged lysine residues is 
a common feature of peptide hydrogels due to its tendency to form 13-sheets, 
the V0 PPT (valine-o-proline-proline-threonine) sequence in the center of this 
peptide is unique in that it adopts a type II ' turn structure. Deprotonation 
of the charged lysine side chains a t pH 9 eliminates electrostatic repulsions 
and triggers intramolecular folding to produce a 13-hairpin with a hydrophobic 
valine face and a hydrophilic lysine face. Lateral assembly into an extended 
13-sheet and facial assembly to bury valine residues produces fibrils that 
further associate into physical hydrogels that are shear-thinning and reversible. 
Modifications to the primary sequence that a lter its hydrophobicity or charge 
state result in different folding and self-assembly in response to changes in 
temperature,46 ionic strength,47 and pH4 8 Light may a lso serve as a trigger for 
13-hairpin formation in a MAX peptide incorporating a photocaged cysteine 
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Figure 5.2 Hydrogel formation from the MAX ~-hairpin oligopeptide. (a) The MAX 
peptide contains alternating Val and Lys residues with the potential to 
form ~-hairpi ns . (b) A stimulus triggers foldin~ of a random coil to a 
~-hairpin, which can then further assemble into fibrils to form a hydrogel. 
The proposed mechanism for fibril self-assembly involves burial of the 
hydrophobic Val face and lateral association of hairpins through inter-
molecular hydrogen bonding. (c) Fibrils can be observed in a diluted 
hydrogel by transmission electron microscopy. 
(Reproduced from Ozbas et al. 41 by permission of the American Chemical 
Society.) 
residue.49 While the replacement of a valine residue with an <X-carboxy-2-
nitrobenzyl-protected cysteine (CNB-Cys) prevents intramolecula r folding, 
cleavage of the protecting group by UV irradiation results in peptide self-
assembly and gelation. Thus, in addition to demonstrating a novel method for 
controlling hydrogel formation, this work also highlights the utility of incor-
porating two non-natural amino acids, o-Pro and CNB-Cys, into hydrogel 
precursors. 
The examples considered thus far involve the gelation of oligopeptides with 
lengths of 10-20 amino acids. An interesting question is how small such pre-
cursor peptides can be while still retaining the ability to self-assemble into 
hydrogels. A number of research groups are addressing this question in their 
investigations of low molecular weight hydrogelators (LMWG).50 In these 
systems, fibrous hydrogels assemble from short peptide sequences, typically 
dipeptides and tripeptides, conjugated to large aromatic groups such as tluor-
enylmethoxycarbonyl (Fmoc). Triggers for LMWG self-assembly include 
acidification to protonate the C-terminus/1•52 temperature change,53 solvent 
change, 54 and enzymatic activity.s5•56 The best studied example of a LMWG is 
the FmocPhePhe dipeptide. Spectroscopic measurements indicating 13-sheet 
formation and 1!- 1! stacking have led to a model for self-assembly in which 
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anti-parallel FmocFF 13-sheets form nanotubcs 3 nm in diameter. 57 The keys to 
nanotube formation appear to be the rr-rr interactions between Fmoc groups on 
adjacent 13-sheets and the twisting of 13-sheets that leads to tube closure. 
Functionalization of LMWG systems with the FmocRGD peptide results in 
hydrogel matrices that support cell attachment ;n vitro. 58 These systems offer 
the potential to form hydrogels from relatively inexpensive and easily synthe-
sized starting materials. 
5.3.2 0!-Helical Coiled-Coil Oligopeptide Hydrogels 
When compared to 13-sheets, ct-helical structures have played a less prominent 
role in the development of hydro gels from synthetic oligopcptides. While there 
are numerous examples of gelating j3-sheet peptides, similar a-helical or coiled-
coil systems have required more careful design to assemble into hydrogcls. As a 
result, the earliest examples of coiled-coil hydrogels were self-assembling 
recombinant proteins 59 and protein-polymer hybrids,60 and only recently have 
research groups reported the gelation of synthetic oligopeptide coiled coils. nl--(' 3 
Coiled-coil peptides are not true a-helices but are closely related.64 The name 
derives from the fact that two helices or coils wrap around one another to form 
a dimer, although higher-order oligomers arc also possible. Rather than the 
expected 3.6 residues per turn for an a-helix, coiled coils complete 3.5 residues 
per turn. A common description of coiled-coil peptide sequences uses an abc-
defg heptad repeat notation, with seven residues representing two turns of the 
helix (Figure 5.3a). The residues at positions a and dare nonpolar and form a 
hydrophobic face to facilitate contact with the other coil (or coils in the case of 
multimcrs). Positions e and fare frequently charged residues while h, c, and g 
are polar. Coiled coils are important motifs in natural proteins, including 
(a) 
e.g 
Electrostatic interactions (b) 
--~~==· R]N I Milllf 
- Nl 
1 Electrostatic 1nteract1ons Asparagine hydrogen bondmg 
*' --- Nl M --- Ni 
*88 & --- N'*ii& --""'N'f' 
Figure 5.3 Coiled-coil pcptidcs and fibers. (a) Helical \vheel representation of a 
coiled-coil dimcr. Dimer formation is driven by hydrophobic association 
of the a and d residues and is often stabilized by electrostati\.: attractions at 
the c and g positions. The h, c. and f positions have important roles in 
controlling: interactions between dimers that govern fiber thickening and 
hydrogel formation. (b) Staggered dimerization leading to fiber formation 
can be enforced by electrostatic interactions (e and g) and asparagine 
hydrogen bonding on the hydrophobic face. 
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transcription factors that must dimerize to bind DNA, and fibrous structural 
proteins such as keratin. The preponderance of leucine at the d position of the 
heptad repeat has given rise to the term "leucine zipper" to describe certain 
coiled coils. 65 
The first step toward coiled-coil peptide hydrogels involves the self-assembly 
of oligopeptides into longer fibers. Kajava and co-workers have formalized 
rules for fiber formation and applied them to the de nora design of homo-
pentamer coils. 66 Their design employs the staggered assembly of coils in the 
axial direction to produce fibers at acidic pH. Zimenkov et a/. have adopted 
some of these rules to form fibers from dimeric coiled coils using a precursor 
peptide containing six heptad repeats. 67 Electrostatic interactions at thee and!? 
positions and a hydrogen bond between asparagine residues on the hydro-
phobic face enforce parallel dimerization between three N-terminal heptads of 
one strand and three C-tenninal heptads of another (Figure 5.3b). The result of 
this staggered arrangement is a dimer with "sticky ends"' that promotes coiled-
coil extension into nanofibers that thicken through lateral association. Using a 
similar strategy, the Woolfson group has developed heterodimeric coiled-coil 
peptides that self-assemble into fibers upon mixing 68·69 Finally, Hartgerink and 
co-workers have demonstrated the formation of uniform fibers from blunt-
ended homodimers with increasing peptide concentratiOns and acidification.02 
A recent review provides additional examples of coiled-coil fiber formation. 70 
Although there arc now several examples of fibers produced by extending 
coiled-coil peptides, only a few have led to hydrogel formation. The Woolfson 
group has engineered their self-assembling fiber system to form hydrogels by 
controlling fiber thickening61 They accomplish this by careful choice of amino 
acids at the h, c, and.fpositions of the coiled-coil heptad. These residues have a 
minimal effect on coil dimerization but mediate the lateral association between 
multiple dimers in solution. Whereas strong electrostatic interactions result in 
thick fibers that settle out of solution,71 weaker interactions can create cross-
link points for a physical hydrogel. When all three residues are glutamine, weak 
gels form but melt as the temperature increases due to a loss of hydrogen 
bonding. Conversely, pcptides with alanine at all three positions form gels that 
strengthen with increasing temperature, an observation that is consistent with 
physical cross-linking mediated by hydrophobic interactions. 
The blunt-ended coiled-coil dimers of the Hartgerink group also form 
reversible, self-supporting gels when sufficiently concentrated. 62 The proposed 
mechanism of gel assembly involves protonation of glutamic acids in the e 
position to reduce electrostatic repulsions. Dexter and co-workers have 
described the similar pH-dependent gelation of a coiled-coil peptide that fea-
tures an expanded hydrophobic face at the a, d. e, and g positions and likely 
assembles as a homohexamer. 63 Charged residues at the h, c, and f positions 
appear to a !Teet the assembly of coiled-coil fibers into hydrogels, with an overall 
charge of + I or I required for gelation. Thus, while examples of hydro gels 
from coiled-coil oligopeptides remain rare compared to 13-sheet hydrogels. 
these recent reports indicate that design rules for this system are beginning 
to emerge. 
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5.3.3 Collagen Mimetic Peptide Hydrogels 
An emerging class of peptide hydrogels is based on the triple-helical structure of 
collagen and its assembly into higher-order fibrous structures. With at least 28 
isoforms, collagens are the most abundant proteins in vertebrates and are 
responsible for much of the mechanical integrity of the extracellular matrix72 
While naturally derived sources of collagens are common materials for cell 
culture and tissue engineering, a synthetic substitute would be more homo-
geneous and eliminate the potential for contamination from animal tissues. To 
realize this goal, several research groups have explored the molecular and 
supramolecular structures of collagen mimetic peptides, or CMPs.73·74 
Early efforts in this field sought to analyze the assembly and stability of 
triple-helical CMPs as a model system for collagen. The most common CMP 
sequences are repeats of the Gly-Pro-Pro (GPP) or Gly-Pro-Hyp (GPO) tri-
peptides, where Hyp (0) is hydroxyproline. These primary sequences adopt a 
left-handed polyproline type II helical structure, and three such helices 
associate as a right-handed superhelix. The requirement for Gly in CMPs stems 
from the steric hindrance encountered by larger side chains in the center of the 
helix, while Pro residues promote the preorganization of helical strands and 
Hyp contributes to stability through solvation or stereoelectronic effects.72 
While researchers have gained important structural information from these 
first-generation CMPs, evidence for their higher-order assembly into fibers and 
gels has been limited75 
As with coiled-coil peptides, progress toward higher-order CMP structures 
requires the extension of triple helices in the axial direction followed by their 
lateral and head-to-tail association into fibers. Kotch and Raines have 
accomplished axial extension using disulfide bonds to create cysteine-knotted 
trimers with single- and double-stranded overhangs at the termini76 The 
overhangs associate with the appropriate strands on opposing molecules to 
extend the triple helix into nanofibers. The Koide group has also developed a 
cysteine knot method for producing long triple-helical CMPs that form 
gels77•78 Chaikof, Conticello and co-workers have described the formation of 
the most collagen-like synthetic fibers to date using a zwitterionic CMP, 
(PRG)4(POG)4(EOGk79 Electrostatic interactions between Arg and Glu side 
chains produce triple helices that further assemble upon thermal annealing into 
70 nm wide fibers with periodic banding patterns similar to those in native 
collagen. Alternative strategies to produce long triple helices involve chain 
extension of telechelic CMPs functionalized with thiols and thioesters for native 
chemicalligation,80 ligands for metal-ion coordination,8 1•82 and aromatic rings 
for n- n stacking and cation- It interactions.83·84 
The Hartgerink group has reported the most comprehensive study to date 
on the hierarchical assembly of CMPs into hydrogels (Figure 5.4)85 Adopting 
an electrostatic sticky-end approach similar to that of Chaikof and Conticello, 
they have demonstrated triple helix formation by a zwitterionic CMP, 
(PKG)4(POG)4(DOGk They hypothesize that replacement of Arg with Lys and 
of Glu with Asp results in more effective salt bridges and improved higher-order 
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Hierarchical assembly of collagen-mimetic peptides. (a) The CMP from 
O'Leary et a/.85 contains Lys and Asp residues that stabilize triple helix 
formation through salt bridges. (b) "Sticky-ended" CMP triple helices form 
fibers in the axial direction. Charged residue that do not participate in 
intra helical salt bridges may promote lateral association of helices. (c) The 
consequence of this design is the formation of long triple-helical CMP 
fibers that further assemble into lateral bundles and entangled hydrogel 
networks. 
(Reproduced from O'Leary et a/.85 by permission of Macmillan 
Publishers.) 
assembly. Nanofibers of width 4-5 nm are consistent with bundling of multiple 
triple helices that further assemble into collagenase-degradable hydrogels. 
A future challenge in the field of CMP hydrogels is the development of 
properly assembling precursor peptides that lack hydroxyproline. While Hyp is 
important for triple helix stabili ty, it has limited researchers to assembling long 
polypeptide chains from short, synthetic oligopeptides rather than recombinant 
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proteins. Using a combination of electrostatic stabilization and cysteine knots, 
Krishna and Kiick have demonstrated the formation of triple helices and 
fibrillar structures from CMPs lacking Hyp 86 Engineering recombinant 
organisms capable of incorporating Hyp during protein synthesisH7 or mod-
ifying proline residues post-translationall/'s would offer alternative solutions. 
5.3.4 Peptide Amphiphile Hydrogels 
Hydrogel formation in many P-shcet and coiled-coil systems is due in part to 
the amphiphilic nature of the precursor peptides. Self-assembly in such mate-
rials results from the burial of apolar regions and a combination of electrostatic 
attractions, hydrogen bonding, and solvation in polar regions. These char-
acteristics are also specific design features of a class of materials known as 
peptide amphiphilcs (PAs). For example, Tirrell and co-workers have synthe-
sized oligopeptides conjugated to long alkyl chains at the N-terminus and 
demonstrated that these hydrophobic tails produce monolayers at an air/water 
interface." The PA monolayers are useful for displaying cell adhesion mole-
cules and orienting peptides to promote intermolecular interactions such as 
triple helix formation in CMPs 90·91 The Zhang group has also developed 
amphiphilic molecules composed completely of amino acids. These PAs 
associate in water to form nanovesicles and nanotubes by burying hydrophobic 
rcsiducs.92 
The Stupp group has thoroughly investigated the selt~asscmbly and gelation 
of peptide amphiphiles, as well as numerous applications for these materials. 
They have synthesized PAs containing a 16-carbon alkyl tail covalently bonded 
to the N-terminus of a hydrophilic peptide.n94 An example of this type of 
molecule is their phosphoserine (S'P04')-containing PA, CHJ(CH2)"0-
CCCCGGGstP04'RGD (C =cysteine). Since the hydrophobic tail is slightly 
narrower than the peptide head, PAs tend to form cylindrical micelles in water. 
Upon slow acidification or addition of calcium ions. PAs self-assemble into 
nanofibers that gel at sufficiently high concentrations. Oxidation of cysteine 
residues creates reversible disulfide cross-links that stabilize PA nanostructures. 
Alternatively. UV-mediated cross-linking can occur between hydrophobic tails 
that contain diacetylene moieties rather than simple alkyl chains." Applica-
tions of PA hydro gels include their use as tissue engineering scaffolds and drug 
delivery vehicles95 The Stupp group's original peptide amphiphiles incorpo-
rated phosphoserine residues that act as templates for the mineralization of 
hydroxyapatite, as observed in bone formation. 93 Nanofibcr and hydrogel 
formation have proven robust to significant sequence variation in the peptide 
region. permitting incorporation of a variety of biologically active peptide 
domains, including those with considerable hydrophobic content. Examples 
include PAs displaying the cell-binding peptides RGD and IK VA V, growth 
factor-mimicking epitopes. and heparin-binding pep tides (I= isoleucine). 94·96·97 
Deming and co-workers have produced rapidly recovering hydrogels from a 
different class of peptide amphiphilcs9 '·99 Using N-carboxyanhydride (NCA) 
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polymerization, they prepared long diblock copolypeptides of the form K 160 L40 
and K, 60Y40 with very low polydispersity. The hydrophobic blocks adopt cr-
helical and P-sheet structures when constituted from leucine (L) and valine, 
respectively. In the case of polyleucine helical hydrophobic blocks, the pro-
posed model for self-assembly involves perpendicular alignment of ex-helices in 
a twisted fibril that is surrounded by a polyelectrolyte "brush". roo This is in 
contrast to other self-assembling helical peptidcs in which alignment occurs 
parallel to the helical axis. Gelation occurs above a concentration threshold 
that is dependent on the length of the hydrophilic block as well as the length 
and structure of the hydrophobic block. Triblock (K,L,Kcl and pcntablock 
(K,L,K_-L,.K,) copolypcptides also self-assemble and form gels, with penta-
blocks having the potential for intermolecular cross-links between fibrils. 101 
5.4 Hydrogels from Recombinant Proteins 
Recombinant proteins are another class of building blocks for engineered 
hydrogels. Whereas oligopeptides prepared by SPPS arc limited in length and 
polypeptides prepared NCA polymerization are limited in sequence diversity, 
recombinant expression exploits the ability of a host organism to synthesize 
full-length proteins of almost any sequence from DNA templates. One result of 
this is a fundamental difference in the mechanisms for hydrogel formation by 
oligopeptides rcrsus recombinant proteins. As discussed in the previous section, 
short oligopeptides self-assemble into nanofibers that entangle to form 
hydrogels. Proteins, on the other hand, can be long enough to form hydrogel 
networks without preassembling into fibers. Instead. network formation is 
driven by noncovalcnt interactions between physical cross-linking domains or 
by covalent bonds between chemically cross-linked residues. 
Protein engineering alTers the potential for unprecedented control over 
hydrogel structure and functionality_:u Two important categories of recom-
binant proteins for hydrogcls arc self-assembling artificial proteins and bio-
mimctic proteins based on elastins and silks. Recent advances in protein 
engineering have also led to the development of a third category that combines 
assembly domains with full length. functional proteins to form multifunctional 
hydrogels. 102 
5.4.1 Self-Assembling, Multidomain Artificial Proteins 
Our laboratory has investigated recombinant artificial proteins as precursors 
for self-assembling hydro gels based on the association of coiled-coil domains. 59 
Telechelic triblock proteins denoted ACYA contain two leucine-zipper domains 
(A) flanking a random coil polyelectrolyte chain, (AG)1PEG, repeated x times 
(CJ. Variation in the association of zipper domains in response to temperature 
and pH changes results in a reversible sol--gel transition. At high temperature or 
high pH, solutions of AC,A behave as viscous liquids. Decreasing the tem-
perature to refold the helices. or lowering the pH to near-neutral values. leads 
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to strong association of leucine-zipper domains as tetramers. Lf the polyelec-
trolyte linker region remains solvated, coiled-coil tetramers can act as physical 
cross-links in a hydrogel network. Using genetically engineered endblocks, 
KopeCck and co-workers have demonstrated that the oligomerization state, 
self-assembly behavior, and pH and temperature responsiveness of coiled-coil 
hydrogcls can be tuned by altering the amino acid sequence. 103•104 
Hydrogels assembled from AC,A triblocks are unexpectedly soft and erode 
rapidly in open solutions, thus limiting their potential applications-' 05 · 106 This 
behavior is due to the tendency of AC_A to form non-productive loops that do 
not contribute to the elasticity of the network. The network is transient and 
rapid exchange of peptide strands between coiled-coil aggregates allows zippers 
to disengage and dissolve in the surrounding medium. Our group has 
demonstrated three strategies that overcome these limitations and produce 
stiffer hydrogels with tunable erosion rates. The first is to stabilize leucine-
zipper aggregates through disulfide bond formation (Figure 5.5a)106 By the 
judicious placement of cysteine residues in the zipper domains, it is possible to 
preferentially stabilize intermolecular aggregates while allowing exchange of 
looped strands. In an alternative strategy, longer polyelectrolyte linkers sup-
press loops that arise to avoid energy penalties associated with stretching 
shorter chains (Figure 5.5b). 105 Unlike typical elastic materials that become 
softer upon increasing the molecular weight between cross-links, AC,A 
hydrogels can become stiffer when the linker region is extended. Finally, 
redesigned triblock proteins of the form AC,P and PC,P (Figure 5.5c), where P 
is a zipper domain derived from the cartilage oligomeric matrix protein, are 
stiffer and exhibit slower erosion rates than AC,A. 107 In the case ofPC,P, these 
observations arise from the higher aggregation number and parallel alignment 
of the P zippers. While A zippers can adopt an anti parallel orientation as part 
of tctramcric coiled coils, P zippers associate exclusively in a parallel orienta-
tion in pentameric aggregates. This results in a lower tendency for PC\.P to 
form intramolecular loops, as the linker region must stretch to permit the 
proper parallel alignment. In the case of AC,P triblocks, intramolecular loops 
rarely form due to the preference of the A and P zippers to aggregate as homo-
oligomers rather than hetero-oligomers. 
The ability to tune the assembly and erosion of telechelic leucine-zipper 
hydrogels suggests a potential application as materials for the encapsulation 
and controlled release of cells or biomolccules. In this respect. desirable features 
include shear-thinning behavior and the rapid recovery of elastic strength upon 
cessation of shear. These properties would permit the delivery of the hydrogel 
and its cargo via a minimally invasive injection. Rheological measurements of 
PCP hydrogels indicate a decrease in the clastic modulus of three orders of 
magnitude at high strain rates (Figure 5.6a). "" Hydrogels also recover their 
elastic strength within seconds after large-amplitude oscillatory strain and form 
self-supporting structures when injected through narrow gauge needles (Figure 
5.6a,b). Shear-thinning appears to be due to yielding behavior within the gel, 
with shear banding potentially protecting cells and biomolecules from high 
shear rates. The nonlinear rheology of PC,P hydro gels is largely unaffected by 
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Figure 5.5 Stabilization of self-assembling artificial proteins to control hydrogel 
stiffness and erosion rate. Cross-links arc depicted as dimers for clarity. 
although tetrameric and pentameric coiled-coils predominate in these 
systems. (a) Disulfide formation between cysteine residues in the AC,A 
domain stabilizes intermolecular cross-links. The protein design precludes 
stabilization of antiparallel intramolecular loops, while parallel loops 
rarely form due to chain stretching. (b) Cross-linking is favored by an 
extended midblock C with a mean end-to-end distance (!c) greater than 
the average distance betv.'een proteins (d). In contrast, shorter midblocks 
form loops to avoid energy penalties associated with chain stretching. 
(c) Proteins of the form PC_.P contain P coil domains that aggregate 
exclusively in a parallel orientation. Cross-linking is preferred to loop 
formation, which requires chain stretching. Proteins of the form AC,P do 
not form intramolecular loops because the A and P domains (white 
rectangles and striped rectangles, respectively) do not form hetero-
oligomers. 
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Figure 5.6 Shear-thinning and elastic recovery of PCP hydrogels. (a) Hydrogels 
experience a decrease in their shear storage modulus (G') of three orders of 
magnitude at the onset of large-amplitude oscillatory strain but recover 
their elastic strength within seconds. Recovery was independent of the 
length of the mid block in PC10P and PC30P hydrogels. (b) PC,P forms a 
self-supporting gel upon injection through a 22 gauge needle. 
(Reproduced from Olsen eta/. 108 by permission of the American Chemical 
Society.) 
the length of the polyelectrolyte linker region, suggesting that it should be 
possible to incorporate biologically active sequences into shear-thinning tele-
chelic proteins. 109 
Telechelic proteins containing collagen-mimetic endblock sequences also 
produce shear-thinning, thermoreversible hydrogels. 110·111 The triblock archi-
tecture of these proteins consists of nine repeats of a Pro-Gly-Pro sequence 
flanking a central random coil. Recombinant production in yeast yields gram-
per-liter quantities of the secreted product. 112 In these materials, endblock 
aggregation occurs through formation of triple helices. Hydrogels assembled 
from CMP telechelic triblocks have shown promise in the controlled release of 
model proteins. 11 3 Chemical cross-linking of lysine residues in the random coil 
midblock using glutaraldehyde produces shape-memory hydrogel networks 
that are dependent on the thermoreversibility of the end block triple helices. 114 
Many peptide hydrogels require temporary exposure to non-physiological 
pH, temperature, or ionic strength in order to self-assemble. These conditions 
may result in unacceptable levels of cell death or denaturation of encapsulated 
cargo. To overcome these problems, Heilshorn and co-workers have introduced 
the mixing-induced, two-component hydrogel (MITCH) system in which 
gelation can occur only upon mixing of two protein solutions. 11 5 The two 
components of MITCH gels are artificial proteins consisting of several repeats 
of either the WW or proline-rich domains separated by random coil linker 
regions. Physical cross-linking between proteins containing the WW domain, 
named for its conserved tryptophan residues, and proteins containing the 
proline-rich domain derives from the noncovalent association between these 
sequences as found in natural proteins. By varying the stoichiometry of the two 
components as well as the frequency and binding strength of the cross-linking 
domains, it is possible to tune the sol- gel transition and viscoelastic properties 
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of the system in a predictable manner. 115• 116 The transient nature of the net-
work results in shear-thinning protein hydrogels that display rapid self-healing 
within minutes after injection. 
5.4.2 Biomimetic Recombinant Proteins: Elastins and Silks 
Elastins a re important components of the extracellular matrix and represent 
attractive targets for biomedical engineering applications. The desirable 
mechanical and chemical properties of elastins can be recapitulated in elastin-
like polypeptides (ELPs) containing repeats of the YPGXG pentamer, where 
the " guest residue" X can be any amino acid except proline. Elastin-like 
polypeptides exhibit inverse temperature behavior in that they are soluble at 
low temperatures but aggregate in coacervate phases at higher temperatures. 
The transition from a soluble to an aggregated state occurs at the lower critical 
solution temperature (LCST), where it has been proposed that ELPs transition 
from a random coil conformation to a ~-spiral. The LCST is dependent on the 
length of the sequence, the ELP concentration, and the hydrophobicity of the 
guest residue, with more hydrophilic sequences exhibiting higher LCSTs. 11 7• 1 ts 
While highly repetitive ELPs can be produced synthetically, recombinant 
engineering permits access to more complex protein/ sequences, including 
multiblock architectures and bioactive domains. 119• 120 One of the most com-
mon engineering strategies is to vary the ELP guest residue to incorporate 
reactive moieties for chemical cross-linking or to alter the LCST behavior of the 
protein. Temperature cycling above and below the LCST offers a facile method 
of purification of recombinant ELPs. 12 1 
Elastin hydrogels have been formed by both physical and chemical cross-
linking methods. Conticello and co-workers have described the physical cross-
linking of triblock ELPs based on inverse temperature transitions. 122•123 The 
mechanism for gel formation is similar to that of telechelic leucine-zipper and 
CMP hydrogels. Triblocks of the form BAB contain hydrophobic endblock 
elastin sequences (B) flanking a hydrophilic elastin midblock (A). At tem-
peratures above their LCST, endblocks undergo microphase separation while 
the hydrophilic midblock (which has a higher LCST) remains solvated. This 
results in hydrogels in which the aggregated hydrophobic blocks serve as 
thermoreversible, noncovalent cross-linkers. Chilkoti and co-workers have 
analyzed the rheological behavior of an ELP above its LCST. Although their 
design did not include explicit cross-linking domains, they observed gel- like 
behavior in the coacervate with potential applications in cartilage tissue 
engineering. 124 
Several research groups have employed chemical cross-linking to form 
hydrogels with mechanical properties that more closely resemble those of native 
elastin. The most common strategy uses small multifunctional cross-linkers that 
form covalent bonds with reactive amino acids, typically lysines occupying the 
ELP guest site or in distinct cross-lin king domains. 125 131 Other strategies 
include enzymatic cross-linking, 132 UV or visible light photo-cross-linking,27•133 
and y-irradiation. 134 
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Hydrogels from silk proteins represent another class of potentially useful 
biomimetic matcrials. 135 The best studied silk proteins are those from the 
Chinese silkworm Bombyx mori and from the draglinc of the spider Nephi/a 
clavipes. Fibers spun from silk proteins derive their impressive mechanical 
strength and extensibility from repetitive Gly- and Ala-rich ~-sheet crystalline 
domains separated by amorphous hydrophilic linker regions. Kaplan and co-
workers have demonstrated that solutions of naturally derived silkworm fibroin 
doped with poly( ethylene glycol) undergo a sol- gel transition over the course of 
days due to the coalescence of hydrophobic rcgions. 136 135 Hydrogels produced 
from silk fibroin are candidates for tissue engineering and cell encapsulation 
applications. 139' 140 
In contrast to extensively engineered ELPs, silk protein engineering has 
generally focused on producing close facsimiles of the natural silks. In parti-
cular, there has been strong interest in developing recombinant sources of 
dragline spider silk since spiders, unlike silkworms, are not easily farmed. 
Several research groups have demonstrated progress in this area by producing 
spider silks in bacterial. 141 plant, 142 mammalian, 14J and silkworm hosts. 144 
While significant attention has been directed toward spinning recombinant silks 
into fibers, only a few studies have examined hydrogel formation from these 
proteins. 145· 146 Further protein engineering could offer the ability to tune the 
mechanical properties of silk and silk hydro gels or to introduce new bioactive 
domains147· 148 An alternative approach to silk-like hydrogels involves geneti-
cally engineered block copolymers of silk-like GAGAGS (S ~serine) peptides 
and elastin-like VPGXG peptides. 14"· 150 Solutions of these proteins sponta-
neously form swollen hydrogels that display the crystalline hydrophobic 
domains of silks and the elasticity and responsiveness of ELPs. These materials 
have shown promise as delivery vehicles for gene therapy. 151 
5.4.3 Multifunctional Protein Hydrogels 
Many proposed applications of peptide hydrogels in tissue engineering and 
drug delivery require materials that display simple binding motifs and assemble 
or disassemble in response to environmental cues. Both oligopeptides and 
recombinant proteins have shown promise in meeting these requirements. 
However, protein engineering also offers the ability to develop hydrogels with 
much more advanced functionality. In this regard, emerging research has 
demonstrated the potential of engineering multifunctional protein hydrogels 
and their applications as sensors and catalytic materials. 
Banta and co-workers have developed multifunctional protein hydrogels that 
combine the self-assembly behavior of leucine zippers with the useful functional 
properties of fluorescent proteins and enzymes. In their initial demonstration of 
this approach, they showed that the incorporation of green fluorescent protein 
in the midblock region of AC,A does not inhibit protein foldmg or gel for-
mation.152 Using this method, they produced multicolor hydro gels and probed 
gel structure in these systems by Forster resonance energy transfer (FRET). A 
similar design that incorporated an oxidase enzyme and electron conductors 
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was used to create bioelectrocatalytic hydrogels capable of reducing molecular 
oxygen to water. 153 The electron-conducting hydrogel network consisted of 
triblock leucine-zipper proteins with osmium bis-bipyridine complexes bound 
to histidine residues. Enzymatic activity was derived from a chimeric protein 
containing a leucine-zipper domain and the small laccase (SLAC) polyphenol 
oxidase from Strepromyces coelico/or. The zipper domain mediates incor-
poration of the chimera into the hydrogel network, while dimerization of the 
SLAC enzyme provides additional cross-linking and is required for catalytic 
activity. This novel class of materials has potential applications in biofuel cells 
and oxygen sensors. Other examples of enzymatic hydrogels incorporate an 
aldo-keto reductase and an organophosphate hydrolase. suggesting the broad 
applicability of this method. 154·155 
In similar work, Gallivan and co-workers have engineered a chimeric cal-
modulin protein fused to a leucine-zipper domain. 156 Calmodulin is an 
important regulatory protein that undergoes a conformational change in the 
presence of calcium ions to bind partner proteins. A solution of the chimeric 
calmodulin-zipper protein and a telechclic cross-linker containing calmodulin-
binding endblocks forms a hydrogel network in the presence of Ca2 + The 
network is reversible upon chelation of calcium. 
5.5 Hydrogels from Peptide-Polymer and Protein-
Polymer Hybrids 
As discussed earlier in this chapter, a common design for recombinant protein 
hydrogels is a telechelic triblock architecture with physical cross-linking 
domains separated by a polyelectrolyte linker. Hydrogel formation results from 
an appropriate balance between endblock aggregation and linker solubility. 
While genetically encoded linkers offer clear advantages such as mono-
dispersity. sequence diversity, and bioactivity, synthetic polymers can also fill 
this role in hydrogels formed from peptide-polymer and protein-polymer 
hybrids. From a synthesis and cost perspective, hydro gels in which the bulk of 
the dry weight derives from synthetic macromolecules may be more desirable 
than hydrogels from oligopeptides or recombinant proteins. Furthermore, 
whereas ribosomal translation limits recombinant proteins to linear archi-
tectures, synthetic methods offer access to branched architectures such as graft, 
star, and dendritic polymers. 
In hybrid hydrogels. peptides and proteins may serve several roles. Most 
commonly, they arc responsible for chemical or physical cross-linking of the 
prepolymer solution. The mechanisms for cross-linking and self-assembly are 
analogous to those described for recombinant protein hydrogels. Peptides and 
proteins may also confer biological activities such as cell binding and enzymatic 
degradability to otherwise inert polymers. Finally, proteins embedded in hybrid 
hydrogel networks may exhibit enzymatic activity or ligand binding for 
applications in stimulus-responsive materials and biosensors. We present 
several examples of hybrid hydrogels as an introduction to this field. A more 
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detailed account of protein- and peptide-polymer materials is provided by 
Krishna and Kiick. 157 
5.5.1 Peptides as Physical and Chemical Cross-Linkers 
Kopecek and co-workers have pioneered the development of physically cross-
linked hybrid hydrogels from proteins and synthetic polymers 60 Their design 
features recombinant coiled-coil proteins attached to a copolymer of N-(2-
hydroxypropyl)methacrylamide and (N' ,N' -dicarboxymethylaminopropyl)-
methacrylamide. The attachment is mediated by Ni'' coordination by the 
polyhistidine tag on the protein and the iminodiacetate side chains of the 
copolymer. As in triblock leucine-zipper recombinant proteins, coiled-coil 
aggregation leads to hydrogel formation. A second generation design features 
two copolymers covalently grafted with coiled coils that associate as hetero-
dimers.15R Reversible hydrogels form upon mixing the two copolymers at 
neutral pH at concentrations as low as 0.1 wt%. 
Sherr and co-workers have further demonstrated the cross-linking potential 
of coiled coils in a bottom-up approach to fabricating hydrogels for 
tissue engineering. 159 Using photolithography, they encapsulate cells in 400 fim 
star-shaped micro gels by photopolymerization of poly( ethylene glycol) (PEG) 
diacrylatc. Subsequent attachment of cysteine-containing coiled coils to the 
residual acrylate groups facilitates reversible assembly ofmicrogels into porous 
macroscopic scaffolds. The high porosity and pore interconnectivity of these 
scaffolds and the short length scales of' the microgels may aid nutrient transport 
to the encapsulated cells. 
The Yu group has investigated hydrogel formation from four-arm PEG stars 
functionalized with collagen-mimetic peptides. 160 The association of CMPs as 
triple helices forms a network that is reversible by heating above the melting 
temperature and addition of competitor CMPs. They exploit this reversible 
behavior to form gradients in gel stiffness through local injection of a hot CMP 
solution. As the solution diffuses from the injection site, the thermal gradient 
melts the triple helical cross-links, \Vhich do not reform upon cooling due to the 
high concentration of competitor peptides. They have also demonstrated the 
use of CMPs to modify natural collagens noncovalently with PEG and growth 
factors through a strand invasion mechanism. 16 1. 102 These systems highlight the 
potential of hybrid hydrogels containing synthetic polymers, peptides, and 
naturally derived proteins. 
Covalent cross-linking offers another route to peptide polymer hydrogels 
(Figure 5.7). Hubbell and co-workers have pioneered the development of 
peptide- and protein-functionalized PEG hydro gels using photopolymerization 
of acrylated precursors and Michael-type addition reactions. 16 ·~- 165 Both 
methods have been used to introduce cell-binding ligands and protease-
sensitive peptide sequences for enzymatic degradation by plasmin and matrix 
metalloproteases. 166· 167 Anseth and co-workers have extended this method for 
cell encapsulation under mild conditions using the bioorthogonal strain-
promoted azide alkyne cycloaddition (SPAAC). To accomplish this, they have 
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Figure 5.7 Chemical and physical cross-linking of four-arm PEG stars. Telechelic 
four-arm PEG is functionalized with vinyl sulfone and azide groups for 
Michael-type addition and strain-promoted azide-alkyne cycloaddition, 
respectively. Chemical cross-linking occurs through difunctional peptides 
that contain terminal cysteines or cyclooctynes. Alternatively. physical 
hydrogels are formed by functionalizing four-arm PEG with collagen-
mimetic peptides that associate noncovalcntly as triple helices. 
cross-linked tetraazide-functionalized four-arm PEG stars with peptides 
containing terminal cyclooctynes.n Their peptide cross-linker also contains 
an alkene moiety for subsequent photopatterning of cell-binding ligands by 
the thiol-ene reaction and a nitrobenzyl ether moiety for controlled 
photodegradation. 168 
5.5.2 Synthetic Hydrogels Containing Functional Protein 
Domains 
In parallel with the development of self-assembling, multifunctional hydrogels 
from recombinant proteins, several groups have demonstrated the potential of 
incorporating functional proteins such as enzymes and antibodies into syn-
thetic polymer scaffolds. For example, two groups have produced calcium-
responsive materials through the covalent incorporation of calmodulin (CaM) 
into cross-linked polyacrylamide (PA) and PEG scaffolds.''" 170 Both networks 
undergo contraction in the presence of Ca2 + and swelling upon its chelation. In 
the case of Ehrick ct a/ .. contraction of the PA hydrogel results from binding 
between CaM and a similarly immobilized CaM ligand. This material has been 
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used to create chemically tunable microlenses. 171 In the system developed by 
Murphy ct al .• conformational changes in CaM drive contraction of the PEG 
scaffold. This system has been used for the controlled release of encapsulated 
growth factors. 172 
Other examples of functional protein polymer hybrids include hydrogels 
that swell and contract due to antigen-antibody binding 173 and catalytic 
activity of grafted enzymes. 174 In addition, there are several examples in which 
growth factors are covalently cross-linked to a polymer scaffold for tissue 
engineering applications. 175- 177 Although the protein components do not 
necessarily contribute to hydrogel assembly or function, these systems still 
represent an important class of hybrid materials. 
5.6 Future Directions and Challenges 
In the past 20 years. the field of peptide and protein hydrogels has grown from 
early observations of self-assembly of oligopeptides to the design of advanced 
materials with \\'ell-controlled biological activity and mechanical properties. 
Hydro gels arc now routinely produced from oligopeptides, recombinant proteins, 
and peptide polymer hybrids. Together with hydrogcls from naturally sourced 
biomolecules and synthetic polymers, these materials provide scientists, engineers, 
and clinicians with a multitude of options to address problems in medicine and 
basic biology. In this regard. an important challenge will be to match the most 
appropriate materials with each application, particularly when transitioning 
hydrogcls into clinical settings. Other challenges include assessing the immune 
response to peptide and protein hydrogcls and producing hydrogel precursors in 
sufficient quantity and purity for their intended applications. These and other 
challenges will guide the design of future generations of engineered hydrogcls. 
5.6.1 Immune Response to Peptide and Protein Hydrogels 
Peptide and protein hydrogels are frequently touted as biocompatible on the 
basis of the fact that their precursors resemble natural biopolymers and should 
be susceptible to enzymatic or hydrolytic degradation. However, implantation 
of hydrogels still has the potential to generate undesirable immune responses. 
While more thorough investigations will be required, initial in rivo and in vitro 
studies to analyze the immunogenicity of peptide hydrogels and their pre-
cursors have been encouraging. For example, using the RADI6 and EAKI6 
pep tides. Holmes eta/. detected no inflammatory response after intramuscular 
injection in rats and no measureable antibody response when the peptides were 
conjugated to bovine serum albumin and injected in rabbits and goats. 178 
Similarly, myocardial injection of RAD 16 hydro gels in mice did not generate 
significant inflammation. 179 while the MAX ~-hairpin hydrogels of the 
Schneider and Pochan groups did not elicit an inflammatory response from 
macrophages in an in vitro assay. 1xo Promising results have also been reported 
for elastin-like and silk-elastin-like materials. 1x1•1x2 
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The Collier group has further investigated the immunogenicity of both 
coiled-coil and ~-sheet self-assembling oligopeptides183- 185 They have 
demonstrated in a mouse model that ~-sheet oligopeptides stimulate antibody 
production only when displaying a strongly immunogenic epitope. 1s4 For 
example, undecorated ~-sheet fibrils and fibrils displaying an RGD motif do 
not elicit an immune response, whereas fibrils that display a 17-mer sequence 
from chicken egg albumin stimulate high titer antibody production. These 
findings suggest that self-assembling peptides may be safe for implantation or 
injection if strongly immunogenic epitopes are avoided. On the other hand. the 
ability of ~-sheet fibrils to enhance the immunogenicity of selected epitopes 
indicates that self-assembling peptidcs may be useful as well-defined adjuvants 
for vaccine delivery and immunotherapy. 
In separate work. Collier and co-workers have demonstrated that, like ~­
sheet fibrils, undecorated coiled coils do not elicit a measureable immune 
response. 185 However, triblock materials consisting of coiled-coil endblocks 
separated by a PEG spacer do stimulate a moderate level of antibody pro-
duction. They suggest that higher molecular weight oligomers may present 
better targets to the immune system, a hypothesis that is consistent with the 
increased immunogcnicity of protein aggregates186 Although this study was 
conducted with peptide concentrations below the gel point, it still highlights a 
key challenge for peptide hydrogels. It may not be possible to predict the 
immunogenicity of hydrogel networks based on the immune response to pre-
cursor peptides and proteins. Further investigation with implanted or injected 
gels will be required. 
5.6.2 New Methods for Peptide Synthesis 
While solid-phase peptide synthesis has been used extensively for hydrogel 
applications. there are several limitations to this method that could hinder 
efforts to scale up peptide production to clinically and industrially useful 
quantities. The foremost limitation is the inverse relationship between peptide 
length and overall yield that precludes the synthesis of polypeptides that 
contain more than approximately 50 amino acids. Low overall yields and the 
poor atom economy of reactions involving large protecting groups and cou-
pling reagents also result in significant amounts of wasted starting material. 
Pattabiraman and Bode have recently reviewed these and other challenges as 
well as promising new methods of amide bond formation and chemoselectivc 
ligation. 18 The development of new reagents and catalysts should be closely 
followed by the peptide hydro gels field. 
Recombinant protein production offers an alternative to SPPS, even for 
small oligopeptides. Riley et a/. have recently described the bioproduction of 
~-sheet peptides that self-assemble into hydrogels. 1" To accomplish this, highly 
repetitive polypeptides are cleaved into oligopeptides at precise positions using 
cyanogen bromide. This method should be applicable to nearly any peptide 
sequence, assuming the appropriate selection of chemical or enzymatic cleavage 
agents. Like SPPS, there are also drawbacks to recombinant protein 
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production. Each new recombinant protein requires cloning to produce the 
template DNA as well as optimization of expression and purification. Protein 
purification frequently involves an affinity chromatography step and the 
removal of lipopolysaccharide endotoxins for therapeutic applications. These 
factors must be considered when choosing between scaling up SPPS or bin-
production of oligopeptides by fermentation. 
5.6.3 Spatially Patterned Hydrogels and Epitopes Beyond RGD 
Owing to their similar mechanical properties and ability to display bioactivc 
domains. peptide and protein hydro gels are excellent candidates to replace the 
extracellular matrix (ECM) in tissue engineering scaffolds and in vitro cell 
culture matrices. While the homogeneity and well-defined nature of peptide and 
protein hydrogels are typically advantageous properties, the natural ECM 
contains mixtures of physical and chemical signals that vary in each tissue. 
These signals are often arranged in gradients or spatial patterns that define the 
cellular microenvironment in such a way as to direct specific cell and tissue 
behaviors. Hydrogels that mimic these patterns will likely be key to recreating 
the morphogenic events observed during development and tissue repair.t\.JHS A 
number of research groups are developing strategies to accomplish this. 1' 9 The 
West, Shoichet, and Anseth groups have created spatial patterns of cell-binding 
peptides and protein growth factors within hydrogels using three-dimensional 
photolithography16'J 90· 191 With these patterns it is possible to direct cell 
behaviors such as spreading and migration. Straley ct a/. have patterned elastin-
like protein hydrogels using spatially controlled enzymatic degradation. 192 
Other potential strategies for hydrogel patterning include layer-by-layer 
assembly using 30 printers 19J. 194 and microfl.uidic approaches. 195 
In addition to spatially patterned hydrogels. more realistic cellular micro-
environments can be obtained by incorporating biologically active domains 
beyond the standard RGD cell-binding sequence. While this tripeptide motif is 
frequently used to demonstrate the cytocompatibility of hydrogels, it binds 
only a subset of integrin receptors and lacks the spatial context normally 
provided by neighboring domains in fibronectin, vitronectin, laminin, or col-
lagen.196·197 More complex cell-binding domains can be engineered into 
hydrogels assembled from recombinant proteins. For example, Fong has 
demonstrated accelerated in l'itro wound healing on elastin-like protein films 
containing the full-length fibronectin type III domains 9 and 10. 1n Wound 
closure on these materials occurs more rapidly than on materials containing 
only the RGD sequence and approaches the rate observed on fibronectin. It is 
also possible to include more biological complexity in hydrogels from oligo-
peptides. Kokkoli and co-workers have developed hydrogels from peptide 
amphiphiles that contain both the RGD cell-binding domain and the PHRSN 
synergy sequence separated by the approximate distance observed in fibro-
nectin (H =histidine, N = asparagine).~'"- 21111 Endothelial cells cultured on these 
materials exhibit high levels of spreading, extracellular matrix deposition, and 
cytoskeletal organization. Together, spatial patterning and more complex 
Peptide and Protein Hydrogcls 117 
epitopes will allow researchers and clinicians to engineer cellular micro-
environments that more closely resemble real tissues without compromising the 
well-defined nature of peptide and protein hydrogels. 
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CHAPTER 6 
Chemomechanical Hydrogels: 
Selective Response towards 
External Effector Molecules 
HANS-JORG SCHNEIDER 
FR Organischc Chemie der Universit~i.t des Saarlandes, 
D-66041 Saarbriicken, Germany 
Email: chl2hs(wrz.uni-sb.de 
6.1 Introduction 
Chemoresponsive materials exhibit size changes by interactions with substances 
in the surrounding medium, representing a special kind of artificial muscle. 
Hydrogels bearing basic or acidic groups in the polymer backbone undergo 
volume changes by pH variation. Such gels can be used to detect, for example, 
glucose after incorporation of glucose oxidase. 1 The application of such enzymes, 
however, suffers from their tendency· to degrade over time: in addition the in viro 
presence of physiologic buffers attenuates the pH response. Until recently, 
chemoresponsive hydrogels were mostly triggered by unspecific interactions, (!.f?. 
by salts or solvents.2 Glucose-sensitive hydrogels were already developed in 1992,1 
on the basis of covalent interactions \vith boronic acids (see Section 6.4). In 
contrast the chemorcsponsive hydrogels mostly dealt with in the present chapter 
bear binding sites which enable selective non-covalent associations. A related 
principle is based on hydrogelators, which can exhibit a macroscopic gel-sol 
transition by external stimuli. 4 Furthermore, gelation itself can be stimulated or 
disrupted by competitive guests, including cavitands as additives. 5 
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